C
California Neuropsychopharmacology Clinical Research Institute | CNRI Los Angeles, CA
Research site
Site insights
Top conditions
Top treatments
Lurasidone
SEP-363856
KarXT
Seroquel
Quetiapine fumarate
NBI-1117568
XEN1101
Lurasidone HCl
ASP4345
moxifloxacin
Parent organization
This site is a part of California Neuropsychopharmacology Clinical Research Institute
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Contact this site
CNRI Los Angeles
Verified by this site
Active trials
1 of 19 total trials
This study will evaluate the long-term safety of NBI-1117568 in adults with schizophrenia.
Enrolling
Schizophrenia
Drug: NBI-1117568
Trial sponsors
P
Clinical trials
Research sites
Resources
Legal
© Copyright 2025 Veeva Systems